Interleukin‑22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway

Zhiqiang Li(Army Medical University), Yu Xiao(Central South University)
Experimental and Therapeutic Medicine
December 19, 2019
Cited by 5


Related Papers